About Mandalmed
Mandalmed is a company based in San Francisco (United States) founded in 2000. Mandalmed offers products and services including Fibrosis Therapies.
- Headquarter San Francisco, United States
- SectorsHealthcare
- Email••••••••
- Website mandalmed.com
- Social LinkedIn
- Legal Name Mandalmed, Inc.
- Latest Funding Round$306.87K (USD), Grant
Aug 2024
- InvestorsHHS
& 2 more
Products & Services of Mandalmed
Mandalmed offers a comprehensive portfolio of products and services, including Fibrosis Therapies.
Develops research-based therapies for fibrosis-related conditions
Funding Insights of Mandalmed
- Total Rounds 12
- Last Round Grant — $306,872
- First Round $492,388
(Jan 2001)
- Investors Count 3
Latest 10 of 12 funding rounds of Mandalmed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2024 | $306,872 | Grant | – | – | |
| Sep 2018 | $299,899 | Grant | – | – | |
| Aug 2016 | $2.23M | Grant | – | – | |
| Sep 2013 | $299,958 | Grant | – | – | |
| Feb 2013 | $749,980 | Grant | – | – | |
| Aug 2011 | $250,000 | Grant | – | – | |
| Aug 2011 | $250,000 | Grant | – | – | |
| Aug 2009 | $241,141 | Grant | – | – | |
| Sep 2008 | $363,936 | Grant | – | – | |
| Sep 2008 | $232,539 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in Mandalmed
Mandalmed has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include HHS, National Cancer Institute and NICHD.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
Child health and human development services are provided nationwide. | 1962 | nichd.nih.gov | Bethesda, United States | |
Cancer research is conducted and supported by the institute. | – | cancer.gov | Bethesda, United States |
Investor details for Mandalmed
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Mandalmed
3 dated milestones of Mandalmed across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Mandalmed is founded.
- Funding First funding round of $492K.
- Funding Latest funding round, Grant, of $307K.
Web traffic of Mandalmed
The website of Mandalmed (mandalmed.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▲ 80.1% vs previous month
Websites whose visitors overlap most with Mandalmed. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| quantatx.com | 100% | 3.1K | #5,909,422 | View details | |
| corvuspharma.com | 100% | 13.6K | #3,366,661 | View details | |
bplifescience.com | bplifescience.com | 100% | – | – | – |
| titanpharm.com | 100% | 4.3K | #4,063,501 | View details | |
| synthexlabs.com | 99% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 31 similar websites and full traffic analytics for Mandalmed
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 31 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Mandalmed
10 companies that operate in the same segment as Mandalmed (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Mandalmed
Mandalmed was founded in 2000 and raised its 1st funding round 1 year after it was founded.
Mandalmed is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Mandalmed was founded in 2000 in San Francisco, United States, within the biotechnology sector. Therapies targeting cancer and spinal cord injuries are advanced through its pipeline, including Galectin-3C, a proprietary truncated form of galectin-3 in Phase 2 trials to inhibit metastasis. Cell-based treatments for spinal cord and traumatic brain injuries are also pursued, involving genetically engineered Sertoli cells that secrete neurotrophins.
Mandalmed offers Fibrosis Therapies.
Mandalmed has 3 investors. Key investors include HHS, National Cancer Institute, and NICHD.
Mandalmed operates through Mandalmed, Inc..